Literature DB >> 804369

Drug metabolism in normal children, lead-poisoned children, and normal adults.

A P Alvares, S Kapelner, S Sassa, A Kappas.   

Abstract

Drug-metabolizing capacities were determined in 10 normal adults and 10 children in the age range from 1 to 8 years. Among the latter, 2 were normal and 8 had biochemical evidence of lead poisoning but no clinical expression of plumbism. There were no differences between the 2 normal children and the 8 lead-poisoned children in their capacities to metabolize two test drugs, antipyrine and phenylbutazone. The mean antipyrine half-life in the whole group of 10 children, 6.63 hr, was significantly lower than the mean half-life of 13.58 obtained in adults. The mean phenylbutazone half-lives in the children and adults, 1.68 and 3.16 days, respectively, also differed significantly. Thus children in the age range studied appear to metabolize drugs at almost twice the rate of adults which differs from findings in animals in which drug-metabolizing capacities increase with maturation. In two other children who showed clinical as well as biochemical manifestations of acute plumbism, antipyrine half-lives were signficantly longer than normal and therapy with EDTA led to restitution toward normal.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 804369     DOI: 10.1002/cpt1975172179

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  23 in total

1.  The association between occupational lead exposure and serum cholesterol and lipoprotein levels.

Authors:  E Kristal-Boneh; D Coller; P Froom; G Harari; J Ribak
Journal:  Am J Public Health       Date:  1999-07       Impact factor: 9.308

2.  Editorial: drug metabolism and increasing age.

Authors: 
Journal:  Br Med J       Date:  1975-06-14

Review 3.  Research review. Interactions between environmental chemicals and drug biotransformation in man.

Authors:  A P Alvares
Journal:  Clin Pharmacokinet       Date:  1978 Nov-Dec       Impact factor: 6.447

4.  Pharmacokinetic observations of phenytoin disposition in the newborn and young infant.

Authors:  P M Loughnan; A Greenwald; W W Purton; J V Aranda; G Watters; A H Neims
Journal:  Arch Dis Child       Date:  1977-04       Impact factor: 3.791

Review 5.  Factors influencing antipyrine elimination.

Authors:  I H Stevenson
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

6.  Effects of dietary lead acetate on hepatic detoxication enzyme activity.

Authors:  D J Wagstaff
Journal:  Bull Environ Contam Toxicol       Date:  1979-12       Impact factor: 2.151

Review 7.  Assessment of methods to identify sources of interindividual pharmacokinetic variations.

Authors:  E S Vesell; M B Penno
Journal:  Clin Pharmacokinet       Date:  1983 Sep-Oct       Impact factor: 6.447

8.  Relationships between plasma theophylline clearance, liver volume and body weight in children and adults.

Authors:  J J Grygiel; H Ward; M Ogborne; A Goldin; D J Birkett
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 9.  Clinical pharmacokinetics of phenylbutazone.

Authors:  J Aarbakke
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

10.  Carbamazepine and its 10,11-epoxide in children and adults with epilepsy.

Authors:  S Pynnönen; M Sillanpää; H Frey; E Iisalo
Journal:  Eur J Clin Pharmacol       Date:  1977-01-03       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.